Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Metric	GILDGilead Sciences	AMGNAmgen	VRTXVertex Pharmaceuticals
Snapshot
Price	$133.81	$407.36	$488.82
Market cap	$162.98B	$201.93B	$115.02B
Valuation
P/E	17.9x	28.4x	28.7x
Forward P/E	12.8x	21.6x	27x
Growth
Revenue growth	3.5%	9.1%	10.1%
EPS growth	55.5%	31.3%	6.1%
Profitability
Net margin	31.0%	21.0%	35.5%
ROE	42.2%	89.4%	23.9%
Balance sheet & cash
Debt / equity	1.1x	6.31x	0.01x
Free cash flow yield	5.2%	6.0%	3.1%
Dividend yield	2.6%	2.9%	—
Verdict
Investment rating	Strong· 74	Favorable· 62	Favorable· 67

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

Year	GILDtoday $134	AMGNtoday $407	VRTXtoday $489
2027	$156.05 – $228.87+71% CAGR	$401.06 – $588.22+44% CAGR	$389.05 – $570.61+17% CAGR
2028	$242.64 – $355.87+63% CAGR	$526.47 – $772.15+38% CAGR	$412.86 – $605.53+11% CAGR
2029	$377.27 – $553.34+61% CAGR	$691.09 – $1,013.60+36% CAGR	$438.13 – $642.59+10% CAGR
2030	$586.62 – $860.38+59% CAGR	$907.20 – $1,330.56+34% CAGR	$464.94 – $681.92+9% CAGR
2031	$912.14 – $1,337.81+58% CAGR	$1,190.88 – $1,746.62+34% CAGR	$493.40 – $723.65+8% CAGR
5-yr CAGR	46.8% – 58.5%	23.9% – 33.8%	0.2% – 8.2%